Eli Lilly Aktie
WKN: 858560 / ISIN: US5324571083
| 19.01.2025 11:05:00 | 
Should You Buy the Dip in Eli Lilly Stock Right Now?
		2024 was an interesting year for pharmaceutical powerhouse Eli Lilly  (NYSE: LLY). At one point, share prices had gained as much as 65% on the year. However, after a less-than-spectacular earnings report published in late October, shares of Lilly started to slide considerably.All told, Lilly stock still gained 33% in 2024, outperforming the S&P 500 and Nasdaq  Composite. Unfortunately, Lilly investors haven't had much to celebrate so far in 2025. On Jan. 14, shares of Lilly dropped by as much as 8% and ended the day down around 6%. Year-to-date, share prices are down about 1.4%.Below, I'm going to dive into what caused Lilly's stock to drop earlier this week and assess if the current price action is a good opportunity to buy the dip.Continue readingWeiter zum vollständigen Artikel bei MotleyFool 
	
	
	 Der finanzen.at Ratgeber für Aktien!
						
						
						
							
								Der finanzen.at Ratgeber für Aktien!
							
							Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Eli Lillymehr Nachrichten
Analysen zu Eli Lillymehr Analysen
| 20.12.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
| 31.10.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
| 13.02.24 | Eli Lilly Buy | Jefferies & Company Inc. | 
Aktien in diesem Artikel
| Eli Lilly | 734,00 | 0,33% |  | 
 
									 
									 
								